Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ex-vivo study of Serenoa repens effects on VEGF expression and microvessel density in benign prostatic hypertrophy
2004-004811-53Phase 4Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of saw palmetto fruit extract in benign prostatic hyperplasia (BPH), sponsored by Pierre Fabre Laboratories. Primary endpoints: VEGF expression in prostate tissue and Microvessel density in prostate tissue. Started Mar 2006; status: completed.
02
Drugs
saw palmetto fruit extract
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on 2004-004811-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004811-53.